Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$13.4K Sell
170
-25
-13% -$1.98K ﹤0.01% 909
2025
Q3
$16.1K Buy
195
+26
+15% +$2.05K ﹤0.01% 850
2025
Q2
$13.7K Buy
169
+44
+35% +$3.4K ﹤0.01% 836
2025
Q1
$10.1K Sell
125
-199
-61% -$16.6K ﹤0.01% 793
2024
Q4
$26.5K Buy
324
+2
+0.6% +$166 ﹤0.01% 679
2024
Q3
$26.6K Buy
322
+2
+0.6% +$149 ﹤0.01% 625
2024
Q2
$22.4K Buy
320
+98
+44% +$7K ﹤0.01% 1040
2024
Q1
$16.4K Buy
222
+2
+0.9% +$139 0.03% 242
2023
Q4
$14.6K Sell
220
-95
-30% -$5.95K ﹤0.01% 709
2023
Q3
$19.9K Hold
315
0.01% 694
2023
Q2
$17.5K Buy
+315
New +$17.5K ﹤0.01% 891

Other funds holding MET

ORG Partners's MET Position: Q4 2025 in Review

ORG Partners reduced its MetLife (MET) stake by 13% in Q4 2025, selling an estimated $1.98K and leaving 170 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

ORG Partners first reported a position in MET in Q2 2023 and has held it in 11 quarters since. The position peaked at $26.6K in Q3 2024. 1,439 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • ORG Partners held 170 shares of MetLife worth $13.4K as of Q4 2025.
  • ORG Partners sold 25 MetLife shares in Q4 2025, an estimated $1.98K.
  • MetLife made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #909 holding.
  • ORG Partners first reported a position in MetLife in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's MetLife position peaked at $26.6K in Q3 2024.
  • 1,439 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.